| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.02. | CORDLIFE GROUP LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FULL YEARLY RESULTS | 1 | SGX Company Announcements | ||
| 14.01. | Cordlife renews cord blood and human tissue banking licences | 2 | Singapore Business Review | ||
| CORDLIFE GROUP Aktie jetzt für 0€ handeln | |||||
| 14.01. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::REGULATORY UPDATE: RENEWAL OF LICENCES | 1 | SGX Company Announcements | ||
| 14.01. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON CLAIMS AGAINST THE COMPANY | 2 | SGX Company Announcements | ||
| 04.12.25 | Cordlife faces $5.45m in claims over 109 damaged cord blood units | 2 | Singapore Business Review | ||
| 02.12.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON CLAIMS AGAINST THE COMPANY | 2 | SGX Company Announcements | ||
| 02.12.25 | CORDLIFE GROUP LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::APPOINTMENT OF NON-INDEPENDENT NON-EXECUTIVE CHAIRMAN | 1 | SGX Company Announcements | ||
| 02.12.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CHANGES TO THE COMPOSITION OF THE BOARD AND BOARD COMMITTEES | 1 | SGX Company Announcements | ||
| 01.12.25 | CORDLIFE GROUP LIMITED: REQUEST FOR LIFTING OF TRADING HALT::REQUEST FOR LIFTING OF TRADING HALT | 4 | SGX Company Announcements | ||
| 01.12.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::REGULATORY UPDATE: RECEIPT OF NOTICE OF REGULATORY ACTION | 2 | SGX Company Announcements | ||
| 27.11.25 | Health ministry suspends Cordlife's blood banking license | 3 | Singapore Business Review | ||
| 27.11.25 | CORDLIFE GROUP LIMITED: REQUEST FOR TRADING HALT::REQUEST FOR TRADING HALT | 2 | SGX Company Announcements | ||
| 14.11.25 | CORDLIFE GROUP LIMITED: REPL::FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::THIRD QUARTER RESULTS | 2 | SGX Company Announcements | ||
| 14.11.25 | CORDLIFE GROUP LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::THIRD QUARTER RESULTS | 1 | SGX Company Announcements | ||
| 30.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CHANGES TO THE COMPOSITION OF THE BOARD AND BOARD COMMITTEES | 1 | SGX Company Announcements | ||
| 30.10.25 | CORDLIFE GROUP LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::CESSATION OF EXECUTIVE CHAIRMAN | 1 | SGX Company Announcements | ||
| 27.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::SUBMISSION OF WRITTEN REPRESENTATIONS TO MOH | 2 | SGX Company Announcements | ||
| 21.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CLARIFICATION TO CERTAIN MEDIA REPORTS | 1 | SGX Company Announcements | ||
| 13.10.25 | Cordlife granted extension to appeal license suspension | 2 | Singapore Business Review | ||
| 13.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::EXTENSION OF TIME GRANTED BY MOH TO PROVIDE WRITTEN REPRESENTATIONS | 1 | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| Q&M DENTAL | 0,200 | -1,96 % | Q & M DENTAL GROUP (SINGAPORE) LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDERS | ||
| SDI LIMITED | - | - | SDI LIMITED: SDI Enters into a Scheme Implementation Deed | ||
| FRESENIUS | 46,590 | +0,41 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Fresenius von 55 auf 57 Euro angehoben und die Einstufung auf "Buy" belassen. Analyst James Vane-Tempest hob am Sonntag im... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,700 | +0,49 % | Siemens Healthineers: Stabilität als strategischer Vorteil | ||
| FRESENIUS MEDICAL CARE | 39,590 | -0,28 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 47,50 auf 46,50 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Das Wachstum der Behandlungszahlen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,790 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| GERRESHEIMER | 18,510 | +2,15 % | Kursexplosion und Kursalarm! Gerresheimer, Nordex und KI-Profiteuer American Atomics! | Kursexplosion bei Nordex. Nach starken Quartalszahlen schießt die Aktie an einem Tag um rund 17 % nach oben. Das Unternehmen schwimmt auf einer Erfolgswelle und der Auftragsbestand deutet darauf hin... ► Artikel lesen | |
| BILLIONTOONE | 72,16 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| GENEDX | 82,09 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 17,610 | 0,00 % | BTIG lowers Progyny stock price target to $30 on client loss impact | ||
| PROCEPT BIOROBOTICS | 25,360 | 0,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
| CARL ZEISS MEDITEC | 25,300 | -0,32 % | INDEX-MONITOR: Lufthansa verpasst Dax-Rückkehr - Nur Wechsel in MDax und SDax | ZUG (dpa-AFX) - Die Aktien von Lufthansa haben die Rückkehr in den deutschen Leitindex Dax verpasst. Wie der zur Deutschen Börse gehörende Index-Anbieter Stoxx am späten Mittwochabend mitteilte, bleibt... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,590 | 0,00 % | Sekundärplatzierung belastet Alignment Healthcare-Aktie | ||
| ESSILORLUXOTTICA | 211,10 | -3,12 % | BARCLAYS stuft EssilorLuxottica auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für EssilorLuxottica mit einem Kursziel von 355 Euro auf "Overweight" belassen. Nutzzahlen zeigten, dass Smartglasses... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,945 | 0,00 % | Barclays raises Lifestance Health stock price target on growth outlook |